Start Date
August 16, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Infliximab + Prednisone
Prednisone dose will be decreased every 3 days for 18 days
Methylprednisolone + Prednisone
Prednisone dose will be decreased every 4 days for 40 days
NYU Langone Medical Center, New York
H Lee Moffitt Cancer Center and Research Institute, Tampa
University of Louisville, Louisville
University of Michigan, Ann Arbor
University of Colorado Cancer Center, Aurora
Huntsman Cancer Institute at The University of Utah, Salt Lake City
Local Institution, Albuquerque
University of California Los Angeles, Los Angeles
Winship Cancer Institute, Emory University, Atlanta
Atlantic Health System, Morristown
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY